头孢他啶杂质H研究

目的：对国产头孢他啶中共有的杂质H进行研究。 方法：制备液相色谱采用Phenomenex Luna C₁₈柱(150 mm×21.2 mm，5 μm)， 流动相A为醋酸盐缓冲液(20 mmol·L^-1醋酸铵，用醋酸调节pH为4.0)，流动相B为乙腈，梯度洗脱，流速15 mL·min^-1，柱温为室温。 收集目标物冻干后利用紫外光谱、红外光谱、 质谱、核磁共振对头孢他啶杂质H进行结构确认；并利用斑马鱼模式生物比较头孢他啶及其杂质H的胚胎发育毒性。 结果：通过实验证实头孢他啶杂质H的结构为(6R， 7R)-7- 氨基] -8-氧代-3-(吡啶-1-鎓-1-基-甲基)-5-硫杂-1-氮杂双环 辛-2-烯-2-甲酸；头孢他啶杂质H在斑马鱼胚胎毒性实验中的致畸作用是头孢他啶的25倍、致死作用是头孢他啶的8倍。 结论：头孢他啶杂质H应予以严格控制。

Objective: To study the common impurity H in domestic ceftazidime. Methods: The HPLC system consisted of a Phenomenex Luna C₁₈ column(150 mm×21.2 mm,5 μm),the mobile phase A was acetate buffer solution(20 mmol·L^-1 ammonium acetate,pH adjusted to 4.0 with acetic acid),the mobile phase B was acetonitrile forgradient elution with the UV detector at 254 nm,the flow rate at 15 mL·min^-1,the column temperature at room temperature.The object was collected and freeze-dried.Ultraviolet spectrum,infrared spectrometry,mass spectrometry and nuclear magnetic resonance were adopted to confirm the chemical structure of ceftazidime impurity H.Thezebrafish was used as an ideal model to compare teratogenesis and toxicity between ceftazidime and impurity H. Results: The chemical structure of ceftazidime impurity H was confirmed to be(6R,7R)-7- acetyl] amino] -8-oxo-3- -5-thia-1-azabicyclo oct-2-ene-2-carboxylate.Ceftazidime impurity H was 25 times higher in teratogenesis and 8times higher in toxicity compared with ceftazidime in zebrafishembryo toxicity test. Conclusion: Ceftazidime impurity H should be controlled strictly.

[1] ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:174
[2] EP 8.0[S].2014:1811
[3] USP 36-NF 31[S].2013:2886
[4] Ferdosian F,Ghiliyan R,Hashemi A,et al.Comparing the efficacy of ceftazidime and meropenem in treatment of febrile neutropenia in pediatric patients with cancer[J].Iran J Ped Hematol Oncol,2013,3(3):103
[5] Richards DM,Brogden RN.Ceftazidime.A review of its antibacterial activity,pharmacokinetic properties and therapeutic use[J].Drugs,1985,29(2):105
[6] Sader HS,Castanheira M,Flamm RK,et al.Antimicrobial activity of ceftazidime-avibactam against gram-negative organisms collected from U.S.Medical Centers in 2012[J].Antimicrob Agents Chemother,2014,58(3):1684
[7] Meyers BR.Comparative toxicities of third-generation cephalosporins[J].Am J Med,1985,79(2A):96
[8] Foord RD.Ceftazidime:aspects of efficacy and tolerance[J].J Antimicrob Chemother,1983,12(Suppl A):399
[9] Picard M,Fernandez MI,Des Roches A,et al.Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms(DRESS)complicated by hemophagocytic lymphohistiocytosis[J].J Allergy Clin Immunol Pract,2013,1(4):409
[10] State Food and Drug Administration(国家食品药品监督管理局).2012 Annual Report of Adverse Drug Reactions(ADR)Monitoring(2012年药品不良反应检测年度报告)[EB/OL].2013-03-14[2013-7-18]http://www.sda.gov.cn/WS01/CL0051/79058.html
[11] SUN Xue-qi(孙雪奇),WANG Ye(王野).Studies on impurities in ceftazidime for injection(注射用头孢他啶杂质研究)[J].Chin J Pharm Anal(药物分析杂志),2012,32(12):2234
[12] YU Ze-min(余泽民),CHEN Ning(陈宁),YANG Shi-zheng(杨世铮),et al.Determination of high molecular weight impurities of cefotaxime,ceftriaxone,ceftazidime(头孢噻肟、头孢曲松、头孢他啶中高分子杂质的含量测定)[J].Chin J Antibiot(中国抗生素杂志),2000,25(5):348
[13] CHEN Ning(陈宁),CAI Heng-dong(蔡恒东),YU Ze-min(余泽民).Improvement of mobile phase in determining high molecular weight impurities of ceftazidime(头孢他啶高分子杂质含量测定中流动相的改进)[J].Chin J Antibiot(中国抗生素杂志),2002,27(1):63
[14] JIANG En-zhu(姜恩铸),HU Chang-qin(胡昌勤).Determination of ceftazidime and impurities using high performance liquid chromatography(高效液相色谱法测定头孢他啶的含量及杂质)[J].Chin J Chromatogr(色谱),2008,26(1):75